Literature DB >> 28017221

Decision-making performance in Parkinson's disease correlates with lateral orbitofrontal volume.

Mutsutaka Kobayakawa1, Natsuko Tsuruya2, Mitsuru Kawamura3.   

Abstract

BACKGROUND: Patients with Parkinson's disease (PD) exhibit poor decision-making, and the underlying neural correlates are unclear. We used voxel-based morphometry with Diffeomorphic Anatomical Registration through Exponentiated Lie algebra to examine this issue.
METHODS: The decision-making abilities of 20 patients with PD and 37 healthy controls (HCs) were measured with a computerized Iowa Gambling Task (IGT). We assessed the local gray matter volumes of the patients and HCs and their correlations with decision-making performance, disease duration, disease severity, and anti-Parkinsonism medication dose.
RESULTS: Compared with the HCs, the patients with PD exhibited poor IGT performances. The gray matter volumes in the medial orbitofrontal cortex, left inferior temporal cortex, and right middle frontal gyrus were decreased in the patients. Results in the regression analysis showed that lateral orbitofrontal volume correlated with performance in the IGT in PD. Regions that correlated with disease duration, severity, and medication dose did not overlap with orbitofrontal regions.
CONCLUSION: Our results indicate that the lateral and medial orbitofrontal cortex are related to decision-making in PD patients. Since the medial orbitofrontal cortex is shown to be involved in monitoring reward, reward monitoring seems to be impaired as a whole in PD patients. Meanwhile, the lateral region is related to evaluation of punishment, which is considered to have an influence on individual differences in decision-making performance in PD patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Decision-making; Orbitofrontal cortex; Parkinson's disease; Voxel-based morphometry

Mesh:

Year:  2016        PMID: 28017221     DOI: 10.1016/j.jns.2016.11.046

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Regional Neural Activity Changes in Parkinson's Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients.

Authors:  Yilan Xing; Shishun Fu; Meng Li; Xiaofen Ma; Mengchen Liu; Xintong Liu; Yan Huang; Guang Xu; Yonggang Jiao; Hong Wu; Guihua Jiang; Junzhang Tian
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-17       Impact factor: 2.570

Review 2.  Global Alterations of Whole Brain Structural Connectome in Parkinson's Disease: A Meta-analysis.

Authors:  Chao Zuo; Xueling Suo; Huan Lan; Nanfang Pan; Song Wang; Graham J Kemp; Qiyong Gong
Journal:  Neuropsychol Rev       Date:  2022-09-20       Impact factor: 6.940

Review 3.  Decision making in Parkinson's disease: An analysis of the studies using the Iowa Gambling Task.

Authors:  Laura Colautti; Paola Iannello; Maria Caterina Silveri; Alessandro Antonietti
Journal:  Eur J Neurosci       Date:  2021-11-09       Impact factor: 3.698

4.  Cognitive and Behavioral Inhibition Deficits in Parkinson's Disease: The Hayling Test as a Reliable Marker.

Authors:  Antònia Siquier; Pilar Andrés
Journal:  Front Aging Neurosci       Date:  2021-01-15       Impact factor: 5.750

5.  Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease.

Authors:  Erin K Donahue; Amjad Murdos; Michael W Jakowec; Nasim Sheikh-Bahaei; Arthur W Toga; Giselle M Petzinger; Farshid Sepehrband
Journal:  Mov Disord       Date:  2021-01-20       Impact factor: 10.338

Review 6.  Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson's Disease?

Authors:  Michael F Salvatore; Isabel Soto; Helene Alphonso; Rebecca Cunningham; Rachael James; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 7.  Olfactory dysfunction in aging and neurodegenerative diseases.

Authors:  Xiuli Dan; Noah Wechter; Samuel Gray; Joy G Mohanty; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2021-07-27       Impact factor: 11.788

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.